Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy

被引：0
作者：
Lan-Lan Pang
Jia-Di Gan
Yi-Hua Huang
Jun Liao
Wei-Tao Zhuang
Wael-Abdullah-Sultan Ali
Shao-Dong Hong
Li Zhang
Wen-Feng Fang
机构：
[1] Sun Yat-Sen University Cancer Center,Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
来源：
BMC Cancer | / 23卷
关键词：
Non-small cell lung cancer; Immunotherapy; Chemotherapy; Combination; Antiangiogenic agents; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[41]   Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC: A Systematic Review and Network Meta-Analysis [J].
Liu, Lihui ;
Bai, Hua ;
Wang, Chao ;
Seery, Samuel ;
Wang, Zhijie ;
Duan, Jianchun ;
Li, Sini ;
Xue, Pei ;
Wang, Guoqiang ;
Sun, Yiting ;
Du, Xinyang ;
Zhang, Xue ;
Ma, Zixiao ;
Wang, Jie .
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (07) :1099-1117
[42]   First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2-altered NSCLC: a retrospective real-world POLISH study [J].
Yang, Guangjian ;
Yang, Yaning ;
Liu, Runze ;
Li, Weihua ;
Xu, Haiyan ;
Hao, Xuezhi ;
Li, Junling ;
Xing, Puyuan ;
Zhang, Shuyang ;
Ai, Xin ;
Xu, Fei ;
Wang, Yan .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
[43]   Economic Analysis of First-Line Treatment with Erlotinib in an EGFR-Mutated Population with Advanced NSCLC [J].
Vergnenegre, Alain ;
Massuti, Bartomeu ;
de Marinis, Filippo ;
Carcereny, Enric ;
Felip, Enriqueta ;
Do, Pascal ;
Miguel Sanchez, Jose ;
Paz-Arez, Luis ;
Chouaid, Christos ;
Rosell, Rafael .
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (06) :801-807
[44]   Quadruple therapy with immunotherapy and chemotherapy as first-line conversion treatment for unresectable advanced gastric adenocarcinoma: A case report [J].
Du, Xiao-Yu ;
Xia, Ren-Jie ;
Shen, Li-Wen ;
Ma, Jian-Guo ;
Yao, Wei-Qing ;
Xu, Wei ;
Lin, Zhi-Peng ;
Ma, Liang-Bin ;
Niu, Guo-Qiang ;
Fan, Rui-Fang ;
Xu, Shu-Mei ;
Yan, Long .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 17 (04)
[45]   First-line treatment of advanced colorectal cancer [J].
Hewish, Madeleine ;
Cunningham, David .
LANCET, 2011, 377 (9783) :2060-2062
[46]   Effectiveness of docetaxel and cisplatin combination as first-line chemotherapy in advanced NSCLC [J].
Behera, D ;
Aggarwal, A ;
Gupta, D ;
Jindal, S ;
Aggarwal, R ;
Sharma, S ;
Kapoor, R .
LUNG CANCER, 2005, 49 :S389-S389
[47]   Impact of Prophylactic Use of PEG-rhG-CSF on First-Line Immunochemotherapy in Advanced NSCLC: A Cohort Study [J].
Sun, Li ;
Tian, Yuan ;
Zhang, Shuling ;
Huang, Letian ;
Ma, Jietao ;
Han, Chengbo .
JTO CLINICAL AND RESEARCH REPORTS, 2025, 6 (02)
[48]   Brigatinib in the first-line treatment of ALK plus metastatic NSCLC: safety and efficacy [J].
Bronte, Giuseppe ;
Cafaro, Alessandro ;
Pasini, Luigi ;
Priano, Ilaria ;
Andrikou, Kalliopi ;
Cravero, Paola ;
Burgio, Marco Angelo ;
Delmonte, Angelo ;
Crino, Lucio .
EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (08) :809-817
[49]   Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes [J].
Blanco, Remei ;
Domine, Manuel ;
Gonzalez, Jose Luis ;
Loutfi, Sami ;
Alfaro, Jordi ;
Saldana, Juana ;
Rubio, Jaime ;
Campos, Begona ;
Hidalgo, Julia ;
Barba, Andres ;
Marquez, Diego ;
Martin, Maria ;
Olaverri, Amaya ;
Nadal, Ernest .
LUNG CANCER, 2023, 183
[50]   The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: an updated systematic review and meta-analysis of randomized controlled trials [J].
Abdelazeem, Basel ;
Abbas, Kirellos Said ;
Labieb, Fatma ;
Arida, Abdul Karim ;
El-Shahat, Nahla Ahmed ;
Shehata, Joseph ;
Kandah, Emad ;
Malik, Bilal ;
Akanbi, Maxwell ;
Rafae, Abdul ;
Wahab, Ahsan ;
Ehsan, Hamid .
EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (10) :1127-1140
12345